Schwann cells as a therapeutic target for peripheral neuropathies

Helmar C. Lehmann, Ahmet Hoke

Research output: Contribution to journalArticle

Abstract

Schwann cells, the myelin forming cells in the peripheral nervous system, play a key role in the pathology of various inflammatory, metabolic and hereditary polyneuropathies. Advances in identifying growth factors and signaling molecules that are expressed by Schwann cells have paved the way for development of new treatment strategies that are aimed to improve the protective and regenerative properties of Schwann cells in peripheral nerve disorders. These include the exogenous application of growth factors and neurohormones which have been advanced into clinical trials in humans, and transplantation paradigms that have been moved into late stage preclinical models. In this review we will discuss the latest developments in these therapeutic approaches with special regard to peripheral nerve disorders, in which progress in basic research has already been translated into clinical trials, including HIV-associated distal sensory polyneuropathy and diabetic neuropathy.

Original languageEnglish (US)
Pages (from-to)801-806
Number of pages6
JournalCNS and Neurological Disorders - Drug Targets
Volume9
Issue number6
StatePublished - 2010

Fingerprint

Schwann Cells
Peripheral Nervous System Diseases
Polyneuropathies
Peripheral Nerves
Intercellular Signaling Peptides and Proteins
Clinical Trials
Diabetic Neuropathies
Peripheral Nervous System
Myelin Sheath
Neurotransmitter Agents
Therapeutics
Transplantation
HIV
Pathology
Research

Keywords

  • Myelination
  • Nerve injury
  • Peripheral nerve
  • Regeneration
  • Schwann cells

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

Schwann cells as a therapeutic target for peripheral neuropathies. / Lehmann, Helmar C.; Hoke, Ahmet.

In: CNS and Neurological Disorders - Drug Targets, Vol. 9, No. 6, 2010, p. 801-806.

Research output: Contribution to journalArticle

@article{ebf2d039774b40e99731e4000301eb3d,
title = "Schwann cells as a therapeutic target for peripheral neuropathies",
abstract = "Schwann cells, the myelin forming cells in the peripheral nervous system, play a key role in the pathology of various inflammatory, metabolic and hereditary polyneuropathies. Advances in identifying growth factors and signaling molecules that are expressed by Schwann cells have paved the way for development of new treatment strategies that are aimed to improve the protective and regenerative properties of Schwann cells in peripheral nerve disorders. These include the exogenous application of growth factors and neurohormones which have been advanced into clinical trials in humans, and transplantation paradigms that have been moved into late stage preclinical models. In this review we will discuss the latest developments in these therapeutic approaches with special regard to peripheral nerve disorders, in which progress in basic research has already been translated into clinical trials, including HIV-associated distal sensory polyneuropathy and diabetic neuropathy.",
keywords = "Myelination, Nerve injury, Peripheral nerve, Regeneration, Schwann cells",
author = "Lehmann, {Helmar C.} and Ahmet Hoke",
year = "2010",
language = "English (US)",
volume = "9",
pages = "801--806",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Schwann cells as a therapeutic target for peripheral neuropathies

AU - Lehmann, Helmar C.

AU - Hoke, Ahmet

PY - 2010

Y1 - 2010

N2 - Schwann cells, the myelin forming cells in the peripheral nervous system, play a key role in the pathology of various inflammatory, metabolic and hereditary polyneuropathies. Advances in identifying growth factors and signaling molecules that are expressed by Schwann cells have paved the way for development of new treatment strategies that are aimed to improve the protective and regenerative properties of Schwann cells in peripheral nerve disorders. These include the exogenous application of growth factors and neurohormones which have been advanced into clinical trials in humans, and transplantation paradigms that have been moved into late stage preclinical models. In this review we will discuss the latest developments in these therapeutic approaches with special regard to peripheral nerve disorders, in which progress in basic research has already been translated into clinical trials, including HIV-associated distal sensory polyneuropathy and diabetic neuropathy.

AB - Schwann cells, the myelin forming cells in the peripheral nervous system, play a key role in the pathology of various inflammatory, metabolic and hereditary polyneuropathies. Advances in identifying growth factors and signaling molecules that are expressed by Schwann cells have paved the way for development of new treatment strategies that are aimed to improve the protective and regenerative properties of Schwann cells in peripheral nerve disorders. These include the exogenous application of growth factors and neurohormones which have been advanced into clinical trials in humans, and transplantation paradigms that have been moved into late stage preclinical models. In this review we will discuss the latest developments in these therapeutic approaches with special regard to peripheral nerve disorders, in which progress in basic research has already been translated into clinical trials, including HIV-associated distal sensory polyneuropathy and diabetic neuropathy.

KW - Myelination

KW - Nerve injury

KW - Peripheral nerve

KW - Regeneration

KW - Schwann cells

UR - http://www.scopus.com/inward/record.url?scp=78649258947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649258947&partnerID=8YFLogxK

M3 - Article

C2 - 20874704

AN - SCOPUS:78649258947

VL - 9

SP - 801

EP - 806

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 6

ER -